Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

656 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
Bártek J, Bártková J, Vojtĕsek B, Stasková Z, Lukás J, Rejthar A, Kovarík J, Midgley CA, Gannon JV, Lane DP. Bártek J, et al. Among authors: kovarik j. Oncogene. 1991 Sep;6(9):1699-703. Oncogene. 1991. PMID: 1923535
Fusion-induced malignancy? A preliminary study. (a challenge to today's common wisdom).
Munzarová M, Lauerová L, Kovarík J, Rejthar A, Brezina V, Kellnerová R, Kovarík A. Munzarová M, et al. Among authors: kovarik j, kovarik a. Neoplasma. 1992;39(2):79-86. Neoplasma. 1992. PMID: 1528312
Rare somatic p53 mutation identified in breast cancer: a case report.
Smardová J, Nemajerová A, Trbusek M, Vagunda V, Kovarík J. Smardová J, et al. Among authors: kovarik j. Tumour Biol. 2001 Mar-Apr;22(2):59-66. doi: 10.1159/000050597. Tumour Biol. 2001. PMID: 11125276
Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
Lauerová L, Dusek L, Simícková M, Rovný F, Spurný V, Rovný A, Slampa P, Zaloudík J, Rejthar A, Wotke J, Kovarík J. Lauerová L, et al. Among authors: kovarik j. Neoplasma. 1999;46(3):141-9. Neoplasma. 1999. PMID: 10613588
p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry.
Smardová J, Vagunda V, Jandáková E, Vagundová M, Koukalová H, Kovarík J, Zaloudík J. Smardová J, et al. Among authors: kovarik j. Neoplasma. 1999;46(6):384-9. Neoplasma. 1999. PMID: 10732868
Up-regulation of Fas (CD95) in human p53wild-type cancer cells treated with ionizing radiation.
Sheard MA, Vojtesek B, Janakova L, Kovarik J, Zaloudik J. Sheard MA, et al. Among authors: kovarik j. Int J Cancer. 1997 Nov 27;73(5):757-62. doi: 10.1002/(sici)1097-0215(19971127)73:5<757::aid-ijc24>3.0.co;2-1. Int J Cancer. 1997. PMID: 9398058
A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.
Speiser P, Gharehbaghi-Schnell E, Eder S, Haid A, Kovarík J, Nenutil R, Sauter G, Schneeberger CH, Vojtesek B, Wiltschke CH, Zeillinger R. Speiser P, et al. Among authors: kovarik j. Br J Cancer. 1996 Jul;74(2):269-73. doi: 10.1038/bjc.1996.350. Br J Cancer. 1996. PMID: 8688334 Free PMC article.
p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence.
Niewolik D, Vojtesek B, Kovarik J. Niewolik D, et al. Among authors: kovarik j. Oncogene. 1995 Mar 2;10(5):881-90. Oncogene. 1995. PMID: 7898929
Immunochemical analysis of the p53 oncoprotein in matched primary and metastatic human tumours.
Bartkova J, Bartek J, Vojtesek B, Lukas J, Rejthar A, Kovarik J, Millis RR, Lane DP, Barnes DM. Bartkova J, et al. Among authors: kovarik j. Eur J Cancer. 1993;29A(6):881-6. doi: 10.1016/s0959-8049(05)80431-9. Eur J Cancer. 1993. PMID: 8484983
Epitope analysis of the human p53 tumour suppressor protein.
Dolezalová H, Vojtĕsek B, Kovarík J. Dolezalová H, et al. Among authors: kovarik j. Folia Biol (Praha). 1997;43(1):49-51. Folia Biol (Praha). 1997. PMID: 9158951
656 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback